Literature DB >> 1909398

Kidney biopsy findings in cyclosporine-treated patients with insulin-dependent diabetes mellitus.

M J Mihatsch1, U Helmchen, P Casanova, R Habib, S Larsen, A Magil, L H Noel, J Rapola, J Ulrich, A C Wallace.   

Abstract

Renal biopsy specimens of 40 patients with recent-onset insulin-dependent diabetes mellitus treated with cyclosporine (CSA) for 6-29 months were examined. Cyclosporine-associated chronic vascular interstitial toxicity of moderate intensity was found in 10 patients (25%). The most prominent lesions were interstitial fibrosis and tubular atrophy. Arteriolopathy was less pronounced and glomerular damage unremarkable. A significant correlation exists between the extent of tubular atrophy and CSA trough whole blood levels. These data indicate that the development of CSA-associated chronic nephropathy is dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909398     DOI: 10.1007/bf02115783

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Cyclosporine treatment in patients with primary glomerular diseases.

Authors:  A Tejani
Journal:  Int J Pediatr Nephrol       Date:  1987 Jan-Mar

2.  Morphology of ciclosporin nephropathy.

Authors:  M J Mihatsch; G Thiel; B Ryffel
Journal:  Prog Allergy       Date:  1986

3.  Morphological patterns in cyclosporine-treated renal transplant recipients.

Authors:  M J Mihatsch; G Thiel; V Basler; B Ryffel; J Landmann; J von Overbeck; H U Zollinger
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

4.  Cyclosporin-associated nephropathy in patients with autoimmune diseases.

Authors:  M J Mihatsch; J F Bach; H M Coovadia; O Førre; H M Moutsopoulos; A A Drosos; K C Siamopoulos; L H Noël; R Ramsaroop; R Hällgren
Journal:  Klin Wochenschr       Date:  1988-01-15

5.  Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

Authors: 
Journal:  Clin Nephrol       Date:  1985-09       Impact factor: 0.975

6.  Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Clinical results and assessment of nephrotoxicity by renal biopsy.

Authors:  P A Miescher; H Favre; F Chatelanat; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1987-08-03

7.  Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis.

Authors:  R S Tindall; J A Rollins; J T Phillips; R G Greenlee; L Wells; G Belendiuk
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

8.  Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

Authors:  C R Stiller; J Dupré; M Gent; M R Jenner; P A Keown; A Laupacis; R Martell; N W Rodger; B von Graffenried; B M Wolfe
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

9.  Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

Authors:  A G Palestine; H A Austin; J E Balow; T T Antonovych; S G Sabnis; H G Preuss; R B Nussenblatt
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

10.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

View more
  1 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.